RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AVXL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Anavex Life Sciences Corp. stock price up 0.593% on Thursday
(Updated on Mar 28, 2024)

Sell candidate since Mar 22, 2024 Gain 9.23% PDF

The Anavex Life Sciences Corp. stock price gained 0.593% on the last trading day (Thursday, 28th Mar 2024), rising from $5.06 to $5.09. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.41% from a day low at $4.98 to a day high of $5.20. The price has been going up and down for this period, and there has been a -0.97% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 62 thousand more shares were traded than the day before. In total, 978 thousand shares were bought and sold for approximately $4.98 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.70% during the next 3 months and, with a 90% probability hold a price between $3.48 and $5.71 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AVXL Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 11.87%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Anavex Life Sciences Corp. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.22. On a fall, the stock will find some support from the short-term average at $4.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Anavex Life Sciences Corp. stock

Anavex Life Sciences Corp. finds support from accumulated volume at $5.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.219 between high and low, or 4.41%. For the last week, the stock has had daily average volatility of 6.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AVXL) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Anavex Life Sciences Corp. to open at $5.09, and during the day (based on 14 day Average True Range), to move between $4.78 and $5.40, which gives a possible trading interval of +/-$0.310 (+/-6.09%) up or down from last closing price. If Anavex Life Sciences Corp. takes out the full calculated possible swing range there will be an estimated 12.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.11 (0.39%) than the support at $5.01 (1.57%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anavex Life Sciences Corp. stock A Buy?

Anavex Life Sciences Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.306 Sell Candidate Unchanged

Predicted Opening Price for Anavex Life Sciences Corp. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$5.09 ( 0.0039%) $5.09

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AVXL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.31 4.31 %
R2 5.23 2.67 %
R1 5.17 1.65 %
Current price: 5.09
Support S1 5.01 -1.64 %
S2 4.95 -2.66 %
S3 4.87 -4.31 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.05 18.76 %
R2 6.01 18.07 %
R1 5.11 0.393 %
Current price 5.09
Support S1 5.01 -1.57%
S2 4.98 -2.16%
S3 4.84 -4.91%

FAQ

What is the symbol for Anavex Life Sciences Corp. Stock and on which exchange is it traded?
The symbol for Anavex Life Sciences Corp. is AVXL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Anavex Life Sciences Corp. Stock?
Anavex Life Sciences Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Anavex Life Sciences Corp. Stock?
Anavex Life Sciences Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Anavex Life Sciences Corp. Stock.

What's the current price of Anavex Life Sciences Corp. Stock?
As of the end of day on the 2024-03-28, the price of an Anavex Life Sciences Corp. (AVXL) share was $5.09.

What is the 52-week high and low for Anavex Life Sciences Corp. Stock?
The 52-week high for Anavex Life Sciences Corp. Stock is $10.31 and the 52-week low is $4.48.

What is the market capitalization of Anavex Life Sciences Corp. Stock?
As of the 2024-03-28, the market capitalization of Anavex Life Sciences Corp. is 411.464M.

When is the next earnings date for Anavex Life Sciences Corp.?
The upcoming earnings date for Anavex Life Sciences Corp. is May 14, 2024.
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT